Results 271 to 280 of about 346,320 (307)
ABSTRACT Background This was a 4‐year mirror‐image study of adult patients diagnosed with bipolar disorder (BD) assessing the effects on treatment continuation and hospitalisation between aripiprazole 1‐month (A1M), risperidone‐LAI (R‐LAI) and the monthly and 3‐monthly formulations of paliperidone palmitate (PP1M, PP3M).
Juan Antonio García‐Carmona +5 more
wiley +1 more source
Health risks of cocaine adulteration: local anesthetics as modulators of monoamine and organic cation transporters. [PDF]
Kudlacek O +9 more
europepmc +1 more source
Background and Purpose Riluzole, approved for amyotrophic lateral sclerosis (ALS), has a glutamate‐modulating profile favourable for mitigating opioid addiction. It reduces neuronal glutamate release and enhances glutamate reuptake, offering advantages over agents that only increase glutamate reuptake.
Ewa Galaj +7 more
wiley +1 more source
Resting-state fMRI analysis of functional connectivity and temporal dynamics differences between cocaine users and healthy controls. [PDF]
Varanasi S +5 more
europepmc +1 more source
Brain stimulation over the dorsolateral prefrontal cortex affects effort‐related cardiovascular responses during a mental concentration task of unclear difficulty in presence of moderate incentives. Right cathodal stimulation leads to higher physiological effort compared to left cathodal and sham stimulation.
David Framorando +2 more
wiley +1 more source
Changes in social reward across adolescence in male mice. [PDF]
Harda Z +9 more
europepmc +1 more source
Glutamate Delta 1 Receptor in Synapses, Circuits, and Disease
This review discusses our current understanding of the structure–function, expression and roles in neural circuits of the less studied glutamate delta 1 (GluD1) receptor. Converging data suggests many unique features of GluD1 including expression at both excitatory and inhibitory synapses and binding to D‐serine and GABA.
Diane Choi +3 more
wiley +1 more source
The rising burden of drug use disorders in the Americas, 2000-2021. [PDF]
Martinez R +6 more
europepmc +1 more source
EAN 2024 Guideline on the Diagnostic Approach to Oligo/Asymptomatic HyperCKemia
ABSTRACT Background Recent epidemiological studies on the general population reveal that up to 1.3% have oligo/asymptomatic hyperCKemia. Objective This guideline aims to provide updated, evidence‐based recommendations on investigating persons older than 18 years.
T. Kyriakides +15 more
wiley +1 more source

